Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Coloured Ties Capital Inc. (TSXV: TIE) (OTC Pink: APEOF) (FSE: 97A0) ("CTI" or the "Company") is pleased to announce a non-brokered private placement of up to 3,750,000 units (each, a "Unit") at a price of $0.20 per Unit for aggregate gross proceeds of up to $750,000 (the "Offering"). Each Unit shall be comprised of one (1) common share in the capital of the Company (each a "Common Share") and one (1) common share purchase warrant (each a "Warrant").

image for news Coloured Ties Capital Inc. Announces Private Placement for Gross Proceeds of up to $750,000

Amazon.com said on Wednesday it is planning to invest $10 billion in North Carolina to expand its cloud computing and artificial intelligence infrastructure.

image for news Amazon to invest $10 billion in North Carolina to expand cloud, AI infrastructure

Antonio Neri, HP CEO, joins 'Money Movers' to discuss the company shares bouncing on earnings, its AI revenues and profit outlook.

image for news We've seen solid demand across all portfolios not just AI, says HP CEO Antonio Neri

Warner Bros. Discovery Shareholders Say 'No' to CEO Zaslav's Pay — Neutral

WBD   Investopedia — June 04, 2025

In a symbolic vote, Warner Bros. Discovery (WBD) shareholders soundly defeated the 2024 compensation packages for CEO David Zaslav and his executive team.

image for news Warner Bros. Discovery Shareholders Say 'No' to CEO Zaslav's Pay

SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease — Positive

SNY   Zacks Investment Research — June 04, 2025

Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.

image for news SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease

Home Depot Stock's High P/E: Justified Premium or Too Pricey to Buy? — Negative

HD   Zacks Investment Research — June 04, 2025

HD's premium valuation raises eyebrows as soft big-ticket sales and economic caution weigh on near-term growth.

image for news Home Depot Stock's High P/E: Justified Premium or Too Pricey to Buy?

Should You Buy, Hold or Sell Costco Stock After Q3 Earnings? — Neutral

COST   Zacks Investment Research — June 04, 2025

Costco Wholesale Corporation COST reported its third-quarter fiscal 2025 results last Thursday after the closing bell, sparking fresh debate among investors about the stock's future direction. As a dominant player in the retail sector, Costco has long been known for its stability and strong customer base, even in the face of broader economic headwinds.

image for news Should You Buy, Hold or Sell Costco Stock After Q3 Earnings?

NEW YORK, NY / ACCESS Newswire / June 4, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151629&wire=1&utm_campaign=27 or contact Joseph E.

image for news Securities Fraud Class Action Filed Against UroGen Pharma Ltd. (URGN) - Levi & Korsinsky Reminds Investors of July 28, 2025

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Ibotta, Inc. ("Ibotta" or the "Company") (NYSE:IBTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Napco Security Technologies, Inc. ("Napco" or the "Company") (NASDAQ:NSSC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Napco Security Technologies, Inc. of Class Action Lawsuit and Upcoming Deadlines - NSSC

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO

Amazon plans to spend $10 billion on new data centers in North Carolina to expand its artificial intelligence infrastructure, the company said. In this article AMZN

image for news Amazon to invest $10 billion in North Carolina data centers in AI push

Ulta Beauty, Inc. (NASDAQ:ULTA ) 2025 dbAccess Global Consumer Conference June 4, 2025 8:45 AM ET Company Participants Kecia L. Steelman - President, CEO & Director Paula M.

image for news Ulta Beauty, Inc. (ULTA) Presents at 2025 dbAccess Global Consumer Conference Transcript

3 Farm Equipment Stocks to Watch Amid Industry Challenges — Negative

AGCO  DE  LNN   Zacks Investment Research — June 04, 2025

The Manufacturing - Farm Equipment industry bears the blunts of low farm income. DE, AGCO and LNN are banking on technology and cost cuts to offset headwinds.

image for news 3 Farm Equipment Stocks to Watch Amid Industry Challenges

Enbridge: "Quintuple Vortex" Exemplified — Positive

ENB   Seeking Alpha — June 04, 2025

Enbridge fails key quality metrics: high debt, slow growth, high capex, unsustainable dividends, and significant shareholder dilution create a value-destructive 'Quintuple Vortex.' Some income statement and cashflow statement issued are elaborated. A meaningful turnaround would require management to prioritize aggressive debt reduction and improved capital allocation before shares become attractive for long-term investors.

image for news Enbridge: "Quintuple Vortex" Exemplified

Gerard Cassidy, RBC Capital Markets global financials research co-head, joins 'Money Movers' to discuss the Fed lifting Wells Fargo's asset cap.

image for news Wells Fargo can finally grow due to the Fed lifting its asset cap, says RBC's Gerard Cassidy

NEW YORK, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-04630, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fortrea securities between July 3, 2023 and February 28, 2025 both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of …

image for news Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE

NEW YORK, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Red Cat Holdings, Inc. ("Red Cat" or the "Company") (NASDAQ:RCAT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-05427, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Red Cat securities between March 18, 2022 and January 15, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' …

image for news Pomerantz Law Firm Announces the Filing of a Class Action Against Red Cat Holdings, Inc. and Certain Officers - RCAT

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Treace Medical Concepts, Inc ("Treace Medical" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI

NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Everus Construction Group, Inc. ("Everus" or the "Company") (NYSE:ECG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG